These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 3785785

  • 1. Are cytosol estrogen and progestin receptors of prognostic significance in the management of epithelial ovarian cancers?
    Schwartz PE, MacLusky N, Merino MJ, Livolsi VA, Kohorn EI, Eisenfeld A.
    Obstet Gynecol; 1986 Dec; 68(6):751-8. PubMed ID: 3785785
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Prognostic significance of estrogen and progesterone receptors in epithelial ovarian cancer.
    Rose PG, Reale FR, Longcope C, Hunter RE.
    Obstet Gynecol; 1990 Aug; 76(2):258-63. PubMed ID: 2371031
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Cytoplasmatic receptors of steroid hormones in malignant epithelial ovarian tumors].
    Makhova EE, Gershteĭn ES, Smirnova KD, Murav'eva NI, Kuz'mina ZV.
    Vopr Onkol; 1984 Aug; 30(12):36-40. PubMed ID: 6516272
    [Abstract] [Full Text] [Related]

  • 12. [Cytosol receptor levels in malignant and benign ovarian tumors].
    Thurzó L, Falkay G, Sas M.
    Orv Hetil; 1987 Aug 30; 128(36):1881-4, 1887. PubMed ID: 3658406
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Estrogen and progesterone receptor status as prognostic indicators in patients with optimally cytoreduced stage IIIc serous cystadenocarcinoma of the ovary.
    Geisler JP, Wiemann MC, Miller GA, Geisler HE.
    Gynecol Oncol; 1996 Mar 30; 60(3):424-7. PubMed ID: 8774651
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Persistence and distribution of estrogen receptor in advanced epithelial ovarian carcinoma after chemotherapy.
    Richman CM, Holt JA, Lorincz MA, Herbst AL.
    Obstet Gynecol; 1985 Feb 30; 65(2):257-63. PubMed ID: 3969239
    [Abstract] [Full Text] [Related]

  • 17. Cytoplasmic estrogen and progesterone receptors as prognostic parameters in primary endometrial carcinoma.
    Liao BS, Twiggs LB, Leung BS, Yu WC, Potish RA, Prem KA.
    Obstet Gynecol; 1986 Apr 30; 67(4):463-7. PubMed ID: 3960417
    [Abstract] [Full Text] [Related]

  • 18. Steroid receptors and hormones in relation to cell proliferation and apoptosis in poorly differentiated epithelial ovarian tumors.
    Lindgren P, Bäckström T, Mählck CG, Ridderheim M, Cajander S.
    Int J Oncol; 2001 Jul 30; 19(1):31-8. PubMed ID: 11408919
    [Abstract] [Full Text] [Related]

  • 19. [Cytosol estrogen, progestin receptors and secretory endometrium in infertile women].
    Ling L.
    Zhonghua Fu Chan Ke Za Zhi; 1989 Jul 30; 24(4):198-200, 251. PubMed ID: 2620570
    [Abstract] [Full Text] [Related]

  • 20. Prognostic value of estrogen receptor and progesterone receptor status in young Chinese ovarian carcinoma patients.
    Yang XY, Xi MR, Yang KX, Yu H.
    Gynecol Oncol; 2009 Apr 30; 113(1):99-104. PubMed ID: 19178934
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.